Skip to main content

Table 2 Summary estimated of diagnostic performance of the 68Ga-PSMA PET/CT for lymph node staging in patient with Prostate Cancer

From: Can 68Ga-prostate specific membrane antigen positron emission tomography/computerized tomography provide an accurate lymph node staging for patients with medium/high risk prostate cancer? A diagnostic meta-analysis

References

Sample size

TPa

FPb

FNc

TNd

Quality

Budaus [25]

30

33

0

67

100

11

Herlemann [20]

34

91

33

9

67

10

Maurer [24]

130

66

1

34

99

11

Gupta [22]

12

100

20

0

80

10

Obek [21]

51

53

14

47

86

10

Van Leeuwen [26]

30

64

5

62

94

11

Zhang [12]

42

93

4

7

96

9

Van Leeuwen [2]

140

60

12

40

88

10

Yilmaz [23]

24

38

6

62

94

10

Yaxley [13]

208

38

6

62

94

11

Pooled analysis

Inconsistency (I2) (95% CI)

99% (98–99)

  

Sample Size

701

  

SENe (95% CI)

0.84 (0.55, 0.95)

  

SPEf (95% CI)

0.95 (0.87, 0.98)

  

PLRg (95% CI)

17.2 (6.3, 47.2)

  

NLRh (95% CI)

0.17 (0.05, 0.56)

  

DORi (95% CI)

100 (18, 545)

  

Youden Index

0.79

  
  1. 68Ga-PSMA PET/CT, 68Gallium-PSMA positron emission tomography/computerized tomography
  2. aTP, true positive
  3. bFP, false positive
  4. cFN, false negative
  5. dTN, true positive
  6. eSEN, Sensitivity
  7. fSPE, Specificity
  8. gPLR, Positive Likelihood Ratio
  9. hNLR, Negative Likelihood Ratio
  10. iDOR, Diagnostic Odds Ratio